Market Overview

5 Stocks Under $5 Making Headlines

Share:
5 Stocks Under $5 Making Headlines

Penny stocks typically don’t cost a penny anymore. Companies trading as high as $5 per share are now considered “penny stocks,” and for good reason. These stocks lack the stability and performance reliability of those with a bigger market cap.

With that said, buying a fiver doesn’t have to be like buying a lottery ticket or pulling the lever on a slot machine; while penny stock investing is some of the most speculative investing you can participate in, there are some small-cap names out there that have a higher chance of performing well than others.

Here are five names that have been featured in some particularly positive Benzinga Pro headlines in the last month or so.

Planet Payment Inc (NASDAQ: PLPM)

This payment processing service provider recently spiked higher following its addition to Louis Navellier’s “Ultimate Growth List.” Its shares have risen 57 percent year-to-date. Ladenburg Thalmann analysts initiated coverage on the company in July with a Buy rating. Planet Payment reports earnings August 3 after hours.

Related Link: 8 Things You Have To Do Before You're 25 For A Secure Retirement

Scorpio Tankers Inc. (NYSE: STNG)

This oil transportation company recently had Deutsche Bank reiterate it as a Top Pick with a Buy rating and a $9 price target, which implies about 90 percent upside. Scorpio reported Q2 results at the end of July, beating EPS consensus estimates. The stock is up about 9 percent since its earnings report.

Sirius XM Holdings Inc. (NASDAQ: SIRI)

Here’s a stock that gets a lot of love from the Vetr crowd, which crowdsources stock ratings. Back in June, the Vetr crowd said it was 100 percent bullish on Sirius XM, believing the stock could return almost 14 percent. Well, at that time, this would have meant a target price of about $4.45. With the stock trading at around $4.22 as of Tuesday afternoon, that still implies about 5 percent upside. While the company had a small miss on the top and bottom line when it reported Q2 earnings recently, it raised both its subscriber growth and revenue guidance for the year.

Groupon Inc (NASDAQ: GRPN)

Groupon grabbed the attention of traders and investors everywhere after a blockbuster of a Q2 earnings report at the end of July. With a smaller-than-expected loss and a huge revenue beat bolstered by a raise in fiscal year guidance, the shares have appreciated about 35 percent since then. Earlier in July, Groupon was upgraded to Overweight by analysts at Piper Jaffray, and Goldman Sachs analysts recently said the company was making positive steps toward full-year profitability.

OncoSec Medical Inc (NASDAQ: ONCS)

Receiving a Buy rating is a notable feather in the cap for any stock, but when it's accompanied by a price target that implies 243 percent of upside, folks tend to give it a second look. Such was the case for OncoSec when Rodman & Renshaw analysts initiated coverage on the stock with a $6 price target. Throw in a Q3 report of a much slimmer loss than expected and positive data from its preliminary ImmunoPulse cancer treatment findings, and it's no wonder the shares have gained 5 percent since the start of summer, even reaching a high of $1.95 during the last trading day of July.

The Takeaway

All the stocks listed above are risky, and are not for those without a substantial risk appetite. Small-caps can present an enticing reward, but should most often be left for investors who aren’t primarily concerned with the preservation of their capital.

Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!

Latest Ratings for PLPM

DateFirmActionFromTo
Oct 2017DowngradesBuyHold
Jul 2016Initiates Coverage onBuy
Dec 2014Initiates Coverage onBuy

View More Analyst Ratings for PLPM
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Long Ideas Penny Stocks Small Cap Analysis Top Stories Analyst Ratings Trading Ideas Best of Benzinga

 

Related Articles (GRPN + ONCS)

View Comments and Join the Discussion!

A Timeline Of Teva's M&A Over The Past Year

Stocks Hitting 52-Week Lows